Stay updated on Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial
Sign up to get notified when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.

Latest updates to the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page
- Check5 days agoChange DetectedThe new screenshot shows Revision: v3.4.3 in the history, replacing Revision: v3.4.2. This is a small metadata update documenting the latest version.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe screenshots depict the same history page with only minor UI/organizational changes and a new version entry added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision: v3.4.2 was added. The funding lapse notice and the Revision: v3.4.1 note were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH Clinical Center status. Updated the revision tag from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedThe history page now includes a glossary display option and color-coded legends for additions and deletions, and revision notes have been updated from v3.3.4 to v3.4.0; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedThe record history now shows a new revision entry (v3.3.4) and the previous revision (v3.3.3) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.